The groundbreaking rise of Viagra has firmly established as a example of pharmaceutical success, yet its position within the broader market now raises questions about potential yields . Copycat versions are diminishing market share, leading to concerns that betting on companies closely tied to Viagra's previous influence could be a dangerous move ,